U.S. Senate Special Committee on Aging

In his continued effort to combat U.S. dependency on foreign-made generic drugs, Florida Congressman Rick Scott (R) announced his Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act during a Senate Special Committee on Aging hearing. During the hearing, titled “Truth in Labeling: Americans Deserve to Know Where […]

Florida Senator Rick Scott (R) continues press for relocating generic drug production from foreign countries, such as India and China, to the U.S. during a hearing with the U.S. Senate Special Committee on Aging. Scott, who is the chairman of the special committee, highlighted various U.S. companies that are successfully producing generic medications domestically, and […]

Florida Senator Rick Scott (R) appeared in a Fox News segment this week where he discussed his push to move generic drug production back to the U.S., as over 90% of U.S. pharmaceuticals originate from countries such as India and China. “Eighty percent of our generic drugs are manufactured in China. Now, number one, China […]

Florida Senator Rick Scott (R) recently led a U.S. Senate Special Committee on how to combat the crucial vulnerabilities in the American pharmaceuticals industry and how to reduce America’s over-reliance on foreign-made generic drugs. Sen. Scott welcomed health experts Tony Sardella, Tony Paquin, and Andrew Rechenberg to testify on potential avenues to bolster domestic generic drug […]

WASHINGTON — Sen. Rick Scott, chairman of the U.S. Senate Special Committee on Aging, held a hearing this week titled “Prescription for Trouble: Drug Safety, Supply Chains, and the Risk to Aging Americans.”  The top concern was the United States' dependence on foreign manufacturers for critical medications and generic drugs. More than 88% of older […]